Risk of Hepatocellular Carcinoma after DAA Treatment in Cirrhotic HIV\textendashHCV-coinfected Patients: Where Do We Stand? - Sorbonne Université
Article Dans Une Revue AIDS Année : 2018

Risk of Hepatocellular Carcinoma after DAA Treatment in Cirrhotic HIV\textendashHCV-coinfected Patients: Where Do We Stand?

Dates et versions

hal-03703935 , version 1 (24-06-2022)

Identifiants

Citer

Karine Lacombe. Risk of Hepatocellular Carcinoma after DAA Treatment in Cirrhotic HIV\textendashHCV-coinfected Patients: Where Do We Stand?. AIDS, 2018, 32 (11), pp.1533--1534. ⟨10.1097/QAD.0000000000001823⟩. ⟨hal-03703935⟩
6 Consultations
0 Téléchargements

Altmetric

Partager

More